ArticleBioengineered2021

miRNA-144 targeting DNAJC3-AS1 reverses the resistance of the breast cancer cell line Michigan Cancer Foundation-7 to doxorubicin.

Ruiping Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.